Advanced in Richter Syndrome

Dr. Sara Robinson

Oncology
1760 E Ken Pratt Blvd Ste 301, 
Longmont, CO 
On Staff At
Accepting New Patients
Offers Telehealth
Advanced in Richter Syndrome
1760 E Ken Pratt Blvd Ste 301, 
Longmont, CO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Sara Robinson is an Oncologist in Longmont, Colorado. Dr. Robinson is rated as an Advanced provider by MediFind in the treatment of Richter Syndrome. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Chronic Lymphocytic Leukemia (CLL), and Pleuropulmonary Blastoma. Dr. Robinson is currently accepting new patients.

Her clinical research consists of co-authoring 3 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
The University Of Texas Medical School At Houston
Residency
University of Colorado School of Medicine
Specialties
Oncology
Licenses
Internal Medicine in CO
Board Certifications
American Board Of Internal Medicine
Fellowships
Baylor University Medical Center
Hospital Affiliations
Boulder Community Health
Centura Health-Avista Adventist Hospital
Medical Center Of The Rockies
Longs Peak Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Rocky Mountain Cancer Centers
1760 E Ken Pratt Blvd Ste 301, Longmont, CO 80504

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Open-Label, Randomized, Multicenter Study Evaluating the Activity of Lasofoxifene Relative to Fulvestrant for the Treatment of Pre- and Postmenopausal Women With Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
An Open-Label, Randomized, Multicenter Study Evaluating the Activity of Lasofoxifene Relative to Fulvestrant for the Treatment of Pre- and Postmenopausal Women With Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Enrollment Status: Completed
Publish Date: January 28, 2026
Intervention Type: Drug
Study Drugs: Lasofoxifene, Fulvestrant
Study Phase: Phase 2
Elacestrant Monotherapy vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, Open-label, Active-controlled, Multicenter Trial
Elacestrant Monotherapy vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, Open-label, Active-controlled, Multicenter Trial
Enrollment Status: Completed
Publish Date: September 15, 2025
Intervention Type: Drug
Study Drugs: Elacestrant, Standard of Care
Study Phase: Phase 3
View 1 Less Clinical Trial

3 Total Publications

Haematological complete remission by ponatinib and bortezomib in a patient with relapsed, Ph⁺ pre-B acute lymphoblastic leukaemia.
Haematological complete remission by ponatinib and bortezomib in a patient with relapsed, Ph⁺ pre-B acute lymphoblastic leukaemia.
Journal: BMJ case reports
Published: April 15, 2014
Similar Doctors
Distinguished in Richter Syndrome
Dr. David J. Andorsky
Oncology
Distinguished in Richter Syndrome
Dr. David J. Andorsky
Oncology

Rocky Mountain Cancer Centers LLP

4715 Arapahoe Ave, 
Boulder, CO 
 (0.1 miles away)
303-385-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Andorsky is an Oncologist in Boulder, Colorado. Dr. Andorsky is rated as a Distinguished provider by MediFind in the treatment of Richter Syndrome. His top areas of expertise are Follicular Lymphoma, Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), and Richter Syndrome. Dr. Andorsky is currently accepting new patients.

Distinguished in Richter Syndrome
Dr. John Burke
Oncology
Distinguished in Richter Syndrome
Dr. John Burke
Oncology

Rocky Mountain Cancer Centers

1700 S Potomac St, 
Aurora, CO 
 (31.4 miles away)
303-418-7600
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

John Burke is an Oncologist in Aurora, Colorado. Dr. Burke is rated as a Distinguished provider by MediFind in the treatment of Richter Syndrome. His top areas of expertise are Non-Hodgkin Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia (CLL), and Large-Cell Immunoblastic Lymphoma. Dr. Burke is currently accepting new patients.

William A. Robinson
Distinguished in Richter Syndrome
Dr. William A. Robinson
Oncology
Distinguished in Richter Syndrome
Dr. William A. Robinson
Oncology

University Physicians Incorporated

12605 E 16th Ave, Uchealth Anschutz Medical, 
Aurora, CO 
 (28.2 miles away)
720-848-0000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

William Robinson is an Oncologist in Aurora, Colorado. Dr. Robinson is rated as a Distinguished provider by MediFind in the treatment of Richter Syndrome. His top areas of expertise are Melanoma, Richter Syndrome, Chronic B-Cell Leukemia (CBCL), and Chronic Lymphocytic Leukemia (CLL). Dr. Robinson is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Robinson's expertise for a condition
ConditionClose
    View All 14 Advanced Conditions
    View All 132 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile